The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Intracellular Accumulation of Insoluble, Newly Synthesized Aβn-42 in Amyloid Precursor Protein-transfected Cells That Have Been Treated with Aβ1–42
Open accessAbstract
Our early study indicates that intracellular Abeta1-42 aggregates are resistant to degradation and accumulate as an insoluble residue in lysosomes, where they alter the normal catabolism of amyloid precursor protein (APP) to cause the accumulation of insoluble APP and amyloidogenic fragments. In this study, we examined whether the addition of exogenous Abeta1-42 also leads to the accumulation of newly synthesized intracellular Abeta. Here we describe that newly synthesized Abeta, especially Abetan-42, is generated from metabolically labeled APP and accumulates in the insoluble fraction of cell lysates after Abeta1-42 treatment. These results suggest that intracellular Abeta may derive from a solid phase, intracellular pathway. In contrast to the pathway that primarily produces secreted Abeta1-40, the solid-phase intracellular pathway preferentially produces Abetan-42 with ragged amino termini. Biochemical studies and amino acid sequencing analyses indicate that these intracellular Abeta also share the same types of Abeta structures that accumulate in the brain of Alzheimer's disease patients, suggesting that a significant fraction of the amyloid deposits in Alzheimer's disease may arise by this solid-phase pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Work in the 1990s had shown that extracellular Aβ1-42 led to marked up-regulation of endogenously generated Aβ42 [51, 211], which also occurs in neurons [190].”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [211]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jarrett, J. T., Berger, E. P., & Lansbury, P. T. (1993) · Biochemistry · doi:10.1021/bi00069a001 · Cited by 2,022
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921
Suzuki, N., Cheung, T. T., Cai, X.-D., Odaka, A., Otvos, L., Eckman, C., Golde, T. E., & Younkin, S. G. (1994) · Science · doi:10.1126/science.8191290 · Cited by 1,471
Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.
Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C., & Glabe, C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48529-8 · Cited by 1,014
Self-citationEvidence that production and release of amyloid beta-protein involves the endocytic pathway
Koo, E. H., & Squazzo, S. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32449-3 · Cited by 829
Roher, A. E., Lowenson, J. D., Clarke, S., Wolkow, C., Wang, R., Cotter, R. J., Reardon, I. M., Zürcher-Neely, H. A., Heinrikson, R. L., & Ball, M. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53661-9 · Cited by 799
Cell Biology of the Amyloid beta-Protein Precursor and the Mechanism of Alzheimer's Disease
Selkoe, D. J. (1994) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.10.110194.002105 · Cited by 748
Roher, A. E., Lowenson, J. D., Clarke, S., Woods, A. S., Cotter, R. J., Gowing, E., & Ball, M. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10836 · Cited by 740
Barrow, C. J., Yasuda, A., Kenny, P. T. M., & Zagorski, M. G. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90106-t · Cited by 644
Miller, D. L., Papayannopoulos, I. A., Styles, J., Bobin, S. A., Lin, Y. Y., Biemann, K., & Iqbal, K. (1993) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1993.1112 · Cited by 510
Research works printed but not linked: 3
- Prusiner, 1987, Lab. Invest., 56, 349
- Joachim, 1991, Am. J. Pathol., 138, 373
- Perry, 1989, Prog. Clin. Biol. Res., 317, 1021
Cited by
Sorted by citations
DeMattos, R. B., Bales, K. R., Cummins, D. J., Dodart, J.-C., Paul, S. M., & Holtzman, D. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151261398 · Cited by 1,298
Masliah, E., Rockenstein, E., Veinbergs, I., Sagara, Y., Mallory, M., Hashimoto, M., & Mucke, L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211412398 · Cited by 607
Regulation of apoptosis-associated lysosomal membrane permeabilization
Johansson, A., Appelqvist, H., Nilsson, C., Kågedal, K., Roberg, K. B., & Öllinger, K. M. (2010) · APOPTOSIS · doi:10.1007/s10495-009-0452-5 · Cited by 479
Zhang, Y., McLaughlin, R., Goodyer, C., & LeBlanc, A. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200110119 · Cited by 418
Busciglio, J., Pelsman, A., Wong, C., Pigino, G., Yuan, M., Mori, H., & Yankner, B. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00604-9 · Cited by 387
Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease
Gouras, G. K., Tampellini, D., Takahashi, R. H., & Capetillo-Zarate, E. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0679-9 · Cited by 372
Crowther, D. C., Kinghorn, K. J., Miranda, E., Page, R., Curry, J. A., Duthie, F., Gubb, D., & Lomas, D. A. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2004.12.025 · Cited by 369
Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity
Chen, S., Berthelier, V., Yang, W., & Wetzel, R. B. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4850 · Cited by 334
RAGE potentiates Aβ‐induced perturbation of neuronal function in transgenic mice
Arancio, O., Zhang, H. P., Chen, X., Lin, C., Trinchese, F., Puzzo, D., Liu, S., Hegde, A. N., Yan, S. F., Stern, A., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600415 · Cited by 333
Fagan, A. M., Watson, M., Parsadanian, M., Bales, K. R., Paul, S. M., & Holtzman, D. M. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0483 · Cited by 290
Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology
Head, E., T. Lott, I., M. Wilcock, D., & A. Lemere, C. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666151020114607 · Cited by 289
Yu, W. H., Kumar, A., Peterhoff, C., Shapiro Kulnane, L., Uchiyama, Y., Lamb, B. T., Cuervo, A. M., & Nixon, R. A. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.05.010 · Cited by 279
Therapeutic strategies for human amyloid diseases
Sacchettini, J. C., & Kelly, J. W. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd769 · Cited by 259
Lorenzo, A., Yuan, M., Zhang, Z., Paganetti, P. A., Sturchler-Pierrat, C., Staufenbiel, M., Mautino, J., Vigo, F. S., Sommer, B., & Yankner, B. A. (2000) · Nature Neuroscience · doi:10.1038/74833 · Cited by 258
Intraneuronal Aβ42 accumulation in Down syndrome brain: Original Articles
Mori, C., Spooner, E. T., Wisniewski, K. E., Wisniewski, T. M., Yamaguchi, H., Saido, T. C., Tolan, D. R., Selkoe, D. J., & Lemere, C. A. (2002) · Amyloid · doi:10.3109/13506120208995241 · Cited by 255
Alpha‐synuclein in Lewy Body Disease and Alzheimer's Disease
Hashimoto, M., & Masliah, E. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00552.x · Cited by 254
Alzheimer disease and Down syndrome: factors in pathogenesis
Lott, I. T., & Head, E. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.08.005 · Cited by 212
Kienlen-Campard, P., Miolet, S., Tasiaux, B., & Octave, J.-N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200887200 · Cited by 187
Aβ42-Peptide Assembly on Lipid Bilayers
Yip, C. M., Darabie, A. A., & McLaurin, J. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00028-1 · Cited by 176
Bayer, T. A., Wirths, O., Majtényi, K., Hartmann, T., Multhaup, G., Beyreuther, K. T., & Czech, C. (2001) · Brain Pathology · doi:10.1111/j.1750-3639.2001.tb00376.x · Cited by 174
JNK activation is associated with intracellular β-amyloid accumulation
Shoji, M., Iwakami, N., Takeuchi, S., Waragai, M., Suzuki, M., Kanazawa, I., Lippa, C. F., Ono, S., & Okazawa, H. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00245-x · Cited by 167
Hawkes, C. A., & Kar, S. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2003.11.002 · Cited by 159
Link, C. D., Johnson, C. J., Fonte, V. G., Paupard, M., Hall, D. H., Styren, S. D., Mathis, C. A., & Klunk, W. E. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00237-2 · Cited by 157
Intracellular Aβ-oligomers and early inflammation in a model of Alzheimer's disease
Ferretti, M. T., Bruno, M. A., Ducatenzeiler, A., Klein, W. L., & Cuello, A. C. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.01.007 · Cited by 151
NF‐κB pathway: a target for preventing β‐amyloid (Aβ)‐induced neuronal damage and Aβ42 production
Valerio, A., Boroni, F., Benarese, M., Sarnico, I., Ghisi, V., Bresciani, L. G., Ferrario, M., Borsani, G., Spano, P., & Pizzi, M. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04722.x · Cited by 148
Pierrot, N., Ghisdal, P., Caumont, A., & Octave, J. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02227.x · Cited by 146
From Cytoprotection to Tumor Suppression: The Multifactorial Role of Peroxiredoxins
Butterfield, L. H., Merino, A., Golub, S. H., & Shau, H. (1999) · Antioxidants and Redox Signaling · doi:10.1089/ars.1999.1.4-385 · Cited by 137
Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid‐β oligomers
Gandy, S., Simon, A. J., Steele, J., Lublin, A. L., Lah, J. J., Walker, L. C., Levey, A. I., Krafft, G. A., Levy, E., Checler, F., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22052 · Cited by 140
Self-citationDown syndrome and beta-amyloid deposition
Head, E., & Lott, I. T. (2004) · Current Opinion in Neurology · doi:10.1097/00019052-200404000-00003 · Cited by 129
Tampellini, D., Rahman, N., Gallo, E. F., Huang, Z., Dumont, M., Capetillo-Zarate, E., Ma, T., Zheng, R., Lu, B., Nanus, D. M., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2292-09.2009 · Cited by 127
Wirths, O., Multhaup, G., Czech, C., Feldmann, N., Blanchard, V., Tremp, G., Beyreuther, K., Pradier, L., & Bayer, T. A. (2002) · Brain Pathology · doi:10.1111/j.1750-3639.2002.tb00442.x · Cited by 125
Pasternak, S., Callahan, J. W., & Mahuran, D. J. (2003) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6107 · Cited by 127
Tampellini, D., Magrané, J., Takahashi, R. H., Li, F., Lin, M. T., Almeida, C. G., & Gouras, G. K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700373200 · Cited by 118
Fuentealba, R. A., Liu, Q., Zhang, J., Kanekiyo, T., Hu, X., Lee, J.-M., LaDu, M. J., & Bu, G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011884 · Cited by 116
Kawahara, K., Suenobu, M., Yoshida, A., Koga, K., Hyodo, A., Ohtsuka, H., Kuniyasu, A., Tamamaki, N., Sugimoto, Y., & Nakayama, H. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.01.049 · Cited by 113
Bi, X., Gall, C. M., Zhou, J., & Lynch, G. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00132-x · Cited by 92
Recent advances on neuronal caspases in development and neurodegeneration
Marks, N., & Berg, M. J. (1999) · Neurochemistry International · doi:10.1016/s0197-0186(99)00061-3 · Cited by 109
Sugarman, M. C., Yamasaki, T. R., Oddo, S., Echegoyen, J. C., Murphy, M. P., Golde, T. E., Jannatipour, M., Leissring, M. A., & LaFerla, F. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082545599 · Cited by 104
Presenilins are not required for Aβ42 production in the early secretory pathway
Wilson, C., Doms, R. W., Zheng, H., & Lee, V. M. ‐. (2002) · Nature Neuroscience · doi:10.1038/nn898 · Cited by 101
GM1 ganglioside regulates the proteolysis of amyloid precursor protein
Zha, Q., Ruan, Y., Hartmann, T., Beyreuther, K. T., & Zhang, D. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001509 · Cited by 101
Pizzi, M., Sarnico, I., Boroni, F., Benarese, M., Steimberg, N., Mazzoleni, G., Dietz, G. P. H., Bähr, M., Liou, H.-C., & Spano, P. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401598 · Cited by 100
Cellular Membrane Composition Defines Aβ-Lipid Interactions
Waschuk, S. A., Elton, E. A., Darabie, A. A., Fraser, P. E., & McLaurin, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103598200 · Cited by 98
Sotiropoulos, I., Catania, C., Riedemann, T., Fry, J. P., Breen, K. C., Michaelidis, T. M., & Almeida, O. F. X. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05613.x · Cited by 97
The Pharmacological Properties and Therapeutic Use of Apomorphine
Ribarič, S. (2012) · Molecules · doi:10.3390/molecules17055289 · Cited by 101
Aβ Internalization by Neurons and Glia
Mohamed, A., & Chaves, E. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/127984 · Cited by 94
Early intraneuronal Aβ deposition in the hippocampus of APP transgenic mice
Shie, F.-S., LeBoeur, R. C., & Jin, L.-W. (2003) · NeuroReport · doi:10.1097/00001756-200301200-00023 · Cited by 70
Cerebellar diffuse amyloid plaques are derived from dendritic Aβ42 accumulations in Purkinje cells
Wang, H.-Y., D’Andrea, M. R., & Nagele, R. G. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00279-2 · Cited by 80
Oxidation of Aβ and Plaque Biogenesis in Alzheimer's Disease and Down Syndrome
Head, E., Garzon-Rodriguez, W., Johnson, J. K., Lott, I. T., Cotman, C. W., & Glabe, C. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0431 · Cited by 75
Self-citationIntracellular A-Beta Amyloid, A Sign for Worse Things to Come?
Echeverría, V., & Cuello, A. C. (2002) · Molecular Neurobiology · doi:10.1385/mn:26:2-3:299 · Cited by 81
Prion-like seeding and nucleation of intracellular amyloid-β
Olsson, T. T., Klementieva, O. L., & Gouras, G. K. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.01.015 · Cited by 74
Armato, U., Chiarini, A., Chakravarthy, B., Chioffi, F., Pacchiana, R., Colarusso, E., Whitfield, J. F., & Dal Prà, I. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.04.020 · Cited by 68
Peptides as Potential Therapeutics for Alzheimer’s Disease
Ribarič, S. (2018) · Molecules · doi:10.3390/molecules23020283 · Cited by 69
The biological role of the Alzheimer amyloid precursor protein in epithelial cells
Schmitz, A., Tikkanen, R., Kirfel, G., & Herzog, V. (2001) · Histochemistry and Cell Biology · doi:10.1007/s00418-001-0351-5 · Cited by 68
Amyloid and Alzheimer's Disease: Inside and Out
Tam, J. H. K., & Pasternak, S. (2012) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100013408 · Cited by 64
Soura, V., Stewart-Parker, M., Williams, T. L., Ratnayaka, J. A., Atherton, J., Gorringe, K., Tuffin, J. P., Darwent, E., Rambaran, R. N., Klein, W. L., et al. (2011) · Biochemical Journal · doi:10.1042/bj20110749 · Cited by 62
Soreghan, B. A., Thomas, S. N., & Yang, A. J. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.07.007 · Cited by 62
Self-citationBiological roles of APP in the epidermis
Herzog, V., Kirfel, G., Siemes, C., & Schmitz, A. (2004) · European Journal of Cell Biology · doi:10.1078/0171-9335-00401 · Cited by 67
Synapses, synaptic activity and intraneuronal Aβ in Alzheimer’s disease
Tampellini, D. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2010.00013 · Cited by 58
Hall, G. F., Lee, V. M. ‐., Lee, G. S., & Yao, J. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63962-4 · Cited by 54
Sakamoto, T., Saito, H., Ishii, K., Takahashi, H., Tanabe, S., & Ogasawara, Y. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.10.075 · Cited by 51
Neuronal spreading and plaque induction of intracellular Aβ and its disruption of Aβ homeostasis
Roos, T. T., Garcia, M. G., Martinsson, I., Mabrouk, R., Israelsson, B., Deierborg, T., Kobro‐Flatmoen, A., Tanila, H., & Gouras, G. K. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02345-9 · Cited by 48
Bignante, E. A., Heredia, F., Morfini, G. A., & Lorenzo, A. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.04.021 · Cited by 50
Increased susceptibility to amyloid toxicity in familial Alzheimer's fibroblasts
Cecchi, C., Fiorillo, C., Baglioni, S., Pensalfini, A., Bagnoli, S., Nacmias, B., Sorbi, S., Nosi, D., Relini, A., & Liguri, G. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.014 · Cited by 48
Down syndrome, beta-amyloid and neuroimaging
Head, E., Helman, A. M., Powell, D. K., & Schmitt, F. A. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.09.013 · Cited by 49
Examination of potential mechanisms of amyloid-induced defects in neuronal transport
Shah, S. B., Nolan, R. L., Davis, E., Stokin, G. B., Niesman, I. R., Canto, I., Glabe, C. G., & Goldstein, L. S. B. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.05.016 · Cited by 45
Self-citationThe Inside-Out Amyloid Hypothesis and Synapse Pathology in Alzheimer's Disease
Gouras, G. K., Willén, K. I., & Faideau, M. (2013) · Neurodegenerative Diseases · doi:10.1159/000354776 · Cited by 42
Impaired β-Amyloid Secretion in Alzheimer's Disease Pathogenesis
Tampellini, D., Rahman, N., Lin, M. T. S., Capetillo‐Zarate, E., & Gouras, G. K. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2986-11.2011 · Cited by 41
Dietary Lipids in the Aetiology of Alzheimer???s Disease
Cooper, J. L. (2003) · Drugs & Aging · doi:10.2165/00002512-200320060-00001 · Cited by 40
Gouras, G. K., Willén, K., & Tampellini, D. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.06.004 · Cited by 39
Spilman, P. R., Corset, V., Gorostiza, O., Poksay, K. S., Galvan, V., Zhang, J., Rao, R., Peters-Libeu, C., Vincelette, J., McGeehan, A., et al. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-151046 · Cited by 39
Rolland, M., Powell, R., Jacquier‐Sarlin, M. R., Boisseau, S., Reynaud-Dulaurier, R., Hernández, J. M., André, L., Borel, E., Buisson, A., & Lanté, F. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.2501-19.2020 · Cited by 41
Griffin, E. F., Yan, X., Caldwell, K. A., & Caldwell, G. A. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy308 · Cited by 34
Johansson, J., Weaver, T. E., & Tjernberg, L. O. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3274-6 · Cited by 30
Rosales‐Corral, S., López-Armas, G. D. C., Cruz-Ramos, J. A., Melnikov, V., Tan, D., Manchester, L. C., Munoz, R., & Reiter, R. J. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/459806 · Cited by 30
Mantha, A. K., Moorthy, K., Cowsik, S. M., & Baquer, N. Z. (2006) · Biogerontology · doi:10.1007/s10522-005-6044-z · Cited by 28
Thomas, S. N., Soreghan, B. A., Nistor, M., Sarsoza, F. M., Head, E., & Yang, A. J. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02892.x · Cited by 29
Self-citationMolecular chaperones and age-related degenerative disorders
Macario, A. J. L., & de Macario, E. C. (2001) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(01)07018-3 · Cited by 25
Intraneuronal Aβ Accumulation, Amyloid Plaques, and Synapse Pathology in Alzheimer’s Disease
Capetillo‐Zarate, E., Gracia, L., Tampellini, D., & Gouras, G. K. (2012) · Neurodegenerative Diseases · doi:10.1159/000334762 · Cited by 25
Lysosomal deposition of Aβ in cultures of brain vascular smooth muscle cells is enhanced by iron
Frackowiak, J., Sukontasup, T., Potempska, A., & Mazur‐Kolecka, B. (2004) · Brain Research · doi:10.1016/j.brainres.2003.12.015 · Cited by 25
Critical thinking on amyloid-beta-targeted therapy: challenges and perspectives
Sun, B., Chen, Y., Fan, D., Zhu, C., Zeng, F., & Wang, Y. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1810-y · Cited by 27
Medical bioremediation of age-related diseases
Mathieu, J. M., Schloendorn, J., Rittmann, B. E., & Alvarez, P. J. J. (2009) · Microbial Cell Factories · doi:10.1186/1475-2859-8-21 · Cited by 26
Antonino, M., Marmo, P., Freites, C. L., Quassollo, G., Sánchez, M. F., Lorenzo, A., & Bignante, E. A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.852738 · Cited by 24
Glabe, C. G., Soreghan, B. A., Pike, C. J., Kayed, R., Tian, W., Milton, S. C. F., & Cotman, C. W. (2002) · NeuroMolecular Medicine · doi:10.1385/nmm:1:1:81 · Cited by 19
Self-citationChaves, E. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y2012-076 · Cited by 18
Convergence of Synapses, Endosomes, and Prions in the Biology of Neurodegenerative Diseases
Gouras, G. K. (2013) · International Journal of Cell Biology · doi:10.1155/2013/141083 · Cited by 17
Targeting intracellular Aβ42 for Alzheimer's disease drug discovery
D’Andrea, M. R., Lee, D. H. S., Wang, H.-Y., & Nagele, R. G. (2002) · Drug Development Research · doi:10.1002/ddr.10075 · Cited by 16
Berrocal, M., Saez, L., & Mata, A. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116055 · Cited by 16
Cuello, A. C., Allard, S., & Ferretti, M. T. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.05.020 · Cited by 15
Hayes, G. M., Howlett, D. R., & Griffin, G. E. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00191-4 · Cited by 14
Regulation of amyloid precursor protein processing by Aβ in human glioma cells
Carlson, C. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00172-x · Cited by 12
Majd, S., Rastegar, K., Zarifkar, A., & Takhshid, M. A. (2007) · Brain Research · doi:10.1016/j.brainres.2007.09.033 · Cited by 12
Kimura, N., Negishi, T., Ishii, Y., Kyuwa, S., & Yoshikawa, Y. (2004) · Neuroscience Research · doi:10.1016/j.neures.2004.03.010 · Cited by 10
Cell Line Specific Modulation of Extracellular Aβ42 by Hsp40
Carnini, A., Scott, L. O. M., Ahrendt, E., Proft, J., Winkfein, R. J., Kim, S.-W., Colicos, M. A., & Braun, J. E. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037755 · Cited by 8
Searching for an in vivo site for nascent amyloid fibril formation
Ali-Khan, Z. (2002) · Journal of Alzheimer s Disease · doi:10.3233/jad-2002-4205 · Cited by 6
NCAM2 promotes targeting of APP from the cell surface to BACE1-containing recycling endosomes
Pfundstein, G., Keable, R., Hu, S., Al-Hadi, M., Baker, M., Schachner, M., Leshchyns’ka, I., & Sytnyk, V. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102807 · Cited by 2
Neuroprotection and Neuroregeneration in Alzheimer's Disease
Sugaya, K., Youdim, M. B. H., Nordberg, A. K., & Rao, K. S. J. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/864138 · Cited by 2
Origin(s) of Intraneuronal Amyloid
D’Andrea, M. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-804256-4.00002-4 · Cited by 2
Hoyer, S., & Frölich, L. (2007) · Springer eBooks · doi:10.1007/978-0-387-30377-2_12 · Cited by 2
Yun, W. B., Park, J. J., Kim, J. E., Sung, J. E., Lee, H. A., Lee, J. H., Bae, C. J., & Hwang, D. Y. (2016) · Laboratory Animal Research · doi:10.5625/lar.2016.32.4.249 · Cited by 2
Amyloid Hypothesis: Molecular and Cellular Aspects of Toxicity
Kayed, R., & Lasagna‐Reeves, C. A. (2013) · Modecular medicine and medicinal · doi:10.1142/9781848167551_0001 · Cited by 2
Metadata
- Authors
- Yang, A. J., Chandswangbhuvana, D., Shu, T., Henschen, A., & Glabe, C. G.
- Affiliations
- Nathan Kline Institute for Psychiatric Research (US)
- University of California, Irvine (US)
- Corresponding author
- Yang, Austin J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1999-07
- Volume
- 274
- Issue
- 29
- Pages
- 20650-20656
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2037197109
- Cited by
- 108
- References
- 39
- Citations by year
- 2026: 1 · 2025: 2 · 2022: 1 · 2021: 2 · 2020: 2 · 2018: 3 · 2017: 1 · 2016: 4 · 2015: 1 · 2013: 5 · 2012: 10
- FWCI
- 6.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Alzheimer's Association
- National Institutes of Health (AG00538)
- National Institute on Aging (AG 00538)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid-beta 42, amyloid precursor protein
- MeSH terms
- Alzheimer Disease, Autoradiography, Cells, Cultured, Chromatography, Gel, Chromatography, High Pressure Liquid, Peptide Fragments, Precipitin Tests, Transfection, Amyloid beta-Peptides, Amyloid beta-Protein Precursor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review